By Associate Professor Amany Zekry

Book Chapters

Chen F; Fryer C; Gong L; Zekry A, 2019, 'Hepatitis B virus, hepatitis C virus, the microbiome and hepatocellular carcinoma', in Eslick G (ed.), Gastrointestinal Diseases and Their Associated Infections, Elsevier, pp. 41 - 54

Gong L; Zekry A, 2019, 'Transplantation Immunology', in Reference Module in Biomedical Research, Elsevier, http://dx.doi.org/10.1016/B978-0-12-801238-3.65668-4

Chen F; Freyer C; Gong L; Zekry A, 2019, 'Chapter 4 Hepatitis B Virus, Hepatitis C Virus, the Microbiome, and Hepatocellular Carcinoma', in Gastrointestinal Diseases and their Associated Infections, Elsevier, pp. 41 - 54, http://dx.doi.org/10.1016/b978-0-323-54843-4.00004-0

McHutchison JG; King JM; Zekry A, 2007, 'New drugs for the management of hepatitis C', in Viral Hepatitis, pp. 540 - 552, http://dx.doi.org/10.1002/9780470987131.ch34

Journal articles

Clark PJ; Valery PC; Ward J; Strasser SI; Weltman M; Thompson A; Levy MT; Leggett B; Zekry A; Rong J; Angus P; George J; Bollipo S; McGarity B; Sievert W; Macquillan G; Tse E; Nicoll A; Wade A; Chu G; Harding D; Cheng W; Farrell G; Roberts SK, 2022, 'Hepatitis C treatment outcomes for Australian First Nations Peoples: equivalent SVR rate but higher rates of loss to follow-up', BMC Gastroenterology, vol. 22, http://dx.doi.org/10.1186/s12876-022-02416-5

Maher S; Rolls S; Pavendranathan G; Westbury S; Akon AC; Zekry A, 2022, 'Virtual clinic for positive faecal occult blood tests enhances early access to bowel cancer screening and is well received by patients', Internal Medicine Journal, vol. 52, pp. 1525 - 1530, http://dx.doi.org/10.1111/imj.15446

Shen S; Khatiwada S; Behary J; Kim R; Zekry A, 2022, 'Modulation of the Gut Microbiome to Improve Clinical Outcomes in Hepatocellular Carcinoma', Cancers, vol. 14, http://dx.doi.org/10.3390/cancers14092099

Amorim N; McGovern E; Raposo A; Khatiwada S; Shen S; Koentgen S; Hold G; Behary J; El-Omar E; Zekry A, 2022, 'Refining a Protocol for Faecal Microbiota Engraftment in Animal Models After Successful Antibiotic-Induced Gut Decontamination', Frontiers in Medicine, vol. 9, http://dx.doi.org/10.3389/fmed.2022.770017

Bensted K; Kim C; Freiman J; Hall M; Zekry A, 2022, 'Gastroenterology hospital outpatients report high rates of satisfaction with a Telehealth model of care', Journal of Gastroenterology and Hepatology (Australia), vol. 37, pp. 63 - 68, http://dx.doi.org/10.1111/jgh.15663

Clark PJ; Valery PC; Strasser SI; Weltman M; Thompson AJ; Levy M; Leggett B; Zekry A; Rong J; Angus P; George J; Bollipo S; McGarity B; Sievert W; Macquillan G; Tse E; Nicoll A; Wade A; Chu G; Harding D; Cheng W; Farrell G; Roberts SK, 2022, 'Liver Disease and Poor Adherence Limit Hepatitis C Cure: A Real-World Australian Treatment Cohort', Digestive Diseases and Sciences, http://dx.doi.org/10.1007/s10620-022-07483-y

Maharaj AD; Lubel J; Lam E; Clark PJ; Duncan O; George J; Jeffrey GP; Lipton L; Liu H; McCaughan G; Neo EL; Philip J; Strasser SI; Stuart K; Thompson A; Tibballs J; Tu T; Wallace MC; Wigg A; Wood M; Zekry A; Greenhill E; Ioannou LJ; Ahlenstiel G; Bowers K; Clarke SJ; Dev A; Fink M; Goodwin M; Karapetis CS; Levy MT; Muller K; O'Beirne J; Pryor D; Seow J; Shackel N; Tallis C; Butler N; Olynyk JK; Reed-Cox K; Zalcberg JR; Roberts SK, 2022, 'Monitoring quality of care in hepatocellular carcinoma: A modified Delphi consensus', Hepatology Communications, http://dx.doi.org/10.1002/hep4.2089

Prince DS; Schlaphoff G; Davison SA; Huo YR; Xiang H; Chan MV; Lee AU; Thailakanathan C; Jebeili H; Rogan C; Al-Omary A; Gupta S; Lockart I; Tiwari N; Clark-Dickson M; Hillhouse JW; Laube R; Chang J; Nguyen V; Danta M; Cheng R; Strasser SI; Zekry A; Levy MT; Chan C; Liu K, 2022, 'Selective internal radiation therapy for hepatocellular carcinoma: A 15-year multicenter Australian cohort study', Journal of Gastroenterology and Hepatology (Australia), http://dx.doi.org/10.1111/jgh.15986

Behary J; Raposo AE; Amorim NML; Zheng H; Gong L; McGovern E; Chen J; Liu K; Beretov J; Theocharous C; Jackson MT; Seet-Lee J; McCaughan GW; El-Omar EM; Zekry A, 2021, 'Defining the temporal evolution of gut dysbiosis and inflammatory responses leading to hepatocellular carcinoma in Mdr2 −/− mouse model', BMC Microbiology, vol. 21, pp. 113, http://dx.doi.org/10.1186/s12866-021-02171-9

Behary J; Amorim N; Jiang XT; Raposo A; Gong L; McGovern E; Ibrahim R; Chu F; Stephens C; Jebeili H; Fragomeli V; Koay YC; Jackson M; O’Sullivan J; Weltman M; McCaughan G; El-Omar E; Zekry A, 2021, 'Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma', Nature Communications, vol. 12, pp. 187, http://dx.doi.org/10.1038/s41467-020-20422-7

Razavi H; Blach S; Razavi-Shearer D; Abaalkhail F; Abbas Z; Abdallah A; Abrao Ferreira P; Abu Raddad LJ; Adda D; Agarwal K; Aghemo A; Ahmed A; Al-Busafi SA; Al-hamoudi W; Al-Kaabi S; Al-Romaihi H; Aljarallah B; AlNaamani K; Alqahtani S; Alswat K; Altraif I; Asselah T; Bacon B; Bessone F; Bizri AR; Block T; Bonino F; Brandão-Mello CE; Brown K; Bruggmann P; Brunetto MR; Buti M; Cabezas J; Calleja JL; Castro Batänjer E; Chan HLY; Chang H; Chen CJ; Christensen PB; Chuang WL; Cisneros L; Cohen C; Colombo M; Conway B; Cooper C; Craxi A; Crespo J; Croes E; Cryer D; Cupertino de Barros FP; Derbala M; Dillon J; Doss W; Dou X; Doyle J; Duberg AS; Dugan E; Dunn R; Dusheiko G; El Khayat H; El-Sayed MH; Eshraghian A; Esmat G; Esteban Mur R; Ezzat S; Falconer K; Fassio E; Ferrinho P; Flamm S; Flisiak R; Foster G; Fung J; García-Samaniego J; Gish RG; Gonçales F; Halota W; Hamoudi W; Hassany M; Hatzakis A; Hay S; Himatt S; Hoepelman IM; Hsu YC; Hui YT; Hunyady B; Jacobson I; Janjua N; Janssen H; Jarcuska P; Kabagambe K; Kanto T; Kao JH; Kaymakoglu S; Kershenobich D; Khamis F; Kim DJ; Kim DY; Kondili LA; Kottilil S; Kramvis A, 2021, 'The case for simplifying and using absolute targets for viral hepatitis elimination goals', Journal of Viral Hepatitis, vol. 28, pp. 12 - 19, http://dx.doi.org/10.1111/jvh.13412

Huang T; Behary J; Zekry A, 2020, 'Non-alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management', Internal Medicine Journal, vol. 50, pp. 1038 - 1047, http://dx.doi.org/10.1111/imj.14709

Nicoll AJ; Roberts SK; Lim R; Mitchell J; Weltman M; George J; Wigg A; Stuart K; Gow P; MacQuillan G; Tse E; Levy M; Sood S; Zekry A; Cheng W; Mitchell J; Skoien R; Sievert W; Strasser SI; McCaughan GW, 2019, 'Beneficial response to mycophenolate mofetil by patients with autoimmune hepatitis who have failed standard therapy, is predicted by older age and lower immunoglobulin G and INR levels', Alimentary Pharmacology and Therapeutics, vol. 49, pp. 1314 - 1322, http://dx.doi.org/10.1111/apt.15248

Pirozyan MR; Nguyen N; Cameron B; Luciani F; Bull RA; Zekry A; Lloyd AR, 2019, 'Chemokine-Regulated Recruitment of Antigen-Specific T-Cell Subpopulations to the Liver in Acute and Chronic Hepatitis C Infection', Journal of Infectious Diseases, vol. 219, pp. 1430 - 1438, http://dx.doi.org/10.1093/infdis/jiy679

Brown MA; Gellatley W; Hoffman A; Dowdell L; Camac A; Francois R; Boston B; Zekry A, 2019, 'Medical complications of homelessness: a neglected side of men’s health', Internal Medicine Journal, vol. 49, pp. 455 - 460, http://dx.doi.org/10.1111/imj.14139

Kwon JA; Dore GJ; Grebely J; Hajarizadeh B; Guy R; Cunningham EB; Power C; Estes C; Razavi H; Gray RT; Dunlop A; Zekry A; Lloyd A; Duvnjak A; Treloar C; Tyrrell H; George J; Iversen J; Marriott K; Crooks L; Maher L; Douglas M, 2019, 'Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study', Journal of Viral Hepatitis, vol. 26, pp. 83 - 92, http://dx.doi.org/10.1111/jvh.13013

Chidwick K; Kiss D; Gray R; Yoo J; Aufgang M; Zekry A, 2018, 'Insights into the management of chronic hepatitis C in primary care using MedicineInsight', Australian journal of general practice, vol. 47, pp. 639 - 645, http://dx.doi.org/10.31128/AJGP-02-18-4482

Sheppard-Law S; Zablotska-Manos I; Kermeen M; Holdaway S; Lee A; George J; Zekry A; Maher L, 2018, 'Utilisation of hepatocellular carcinoma screening in Australians at risk of hepatitis B virus-related carcinoma and prescribed anti-viral therapy', Journal of Clinical Nursing, vol. 27, pp. 2673 - 2683, http://dx.doi.org/10.1111/jocn.14367

Brown A; Hézode C; Zuckerman E; Foster GR; Zekry A; Roberts SK; Lahser F; Durkan C; Badshah C; Zhang B; Robertson M; Wahl J; Barr E; Haber B, 2018, 'Efficacy and safety of 12 weeks of elbasvir ± grazoprevir ± ribavirin in participants with hepatitis C virus genotype 2, 4, 5 or 6 infection: The C-SCAPE study', Journal of Viral Hepatitis, vol. 25, pp. 457 - 464, http://dx.doi.org/10.1111/jvh.12801

Roberts SK; Lim R; Strasser S; Nicoll A; Gazzola A; Mitchell J; Siow W; Khoo T; Hamarneh Z; Weltman M; Gow P; Janko N; Tse E; Mishra G; Cheng EH; Levy M; Cheng W; Sood S; Skoien R; Mitchell J; Zekry A; George J; MacQuillan G; Wigg A; Stuart K; Sievert W; McCaughan G, 2018, 'Efficacy and Safety of Mycophenolate Mofetil in Patients With Autoimmune Hepatitis and Suboptimal Outcomes After Standard Therapy', Clinical Gastroenterology and Hepatology, vol. 16, pp. 268 - 277, http://dx.doi.org/10.1016/j.cgh.2017.09.063

Sheppard-Law S; Zablotska-Manos I; Kermeen M; Holdaway S; Lee A; George J; Zekry A; Maher L, 2018, 'Factors associated with non-adherence to HBV antiviral therapy', Antiviral Therapy, vol. 23, pp. 425 - 433, http://dx.doi.org/10.3851/IMP3219

Sud R; Tiwari N; Forner P; Dowdell L; Freiman J; Zekry A, 2018, 'General practitioners require more support to prescribe direct acting antiviral therapy for hepatitis C', Internal Medicine Journal, vol. 48, pp. 105 - 106, http://dx.doi.org/10.1111/imj.13662

Nicoll A; Roberts SK; Lim R; Mitchell J; Weltman M; George J; Wigg A; Stuart K; Gow P; MacQuillan G; Tse E; Levy MT; Sood S; Zekry A; Cheng W; Mitchell J; Skoien R; Sievert W; Strasser S; McCaughan G, 2018, 'Mo1458 - Response to Mycphenolate Mofetil in Patents with Autoimmune Hepatitis who Fail Standard Therapy is Predicted by Serum Gammaglobulin Levels but not Cirrhosis', Gastroenterology, vol. 154, pp. S - 1213, http://dx.doi.org/10.1016/s0016-5085(18)34006-x

Aggarwal V; Day AS; Connor S; Leach ST; Brown G; Singh R; Friedman A; Zekry A; Craig PI, 2017, 'Role of capsule endoscopy and fecal biomarkers in small-bowel Crohn's disease to assess remission and predict relapse', Gastrointestinal Endoscopy, vol. 86, pp. 1070 - 1078, http://dx.doi.org/10.1016/j.gie.2017.09.011

Polis S; Zhang L; Mainali B; Pons R; Pavendranathan G; Zekry A; Fernandez R, 2017, 'Factors associated with medication adherence in patients living with cirrhosis (vol 25, pg 204, 2016)', JOURNAL OF CLINICAL NURSING, vol. 26, pp. 3751 - 3751, http://dx.doi.org/10.1111/jocn.14074

Polis S; Zablotska-Manos I; Zekry A; Maher L, 2017, 'Adherence to Hepatitis B antiviral therapy: A qualitative study', Gastroenterology Nursing, vol. 40, pp. 239 - 246, http://dx.doi.org/10.1097/SGA.0000000000000161

Sheppard-Law S; Zablotska-Manos I; Kermeen M; Holdaway S; Lee A; Zekry A; Dore GJ; George J; Maher L, 2017, 'Factors associated with HBV virological breakthrough', Antiviral Therapy, vol. 22, pp. 53 - 60, http://dx.doi.org/10.3851/IMP3087

Lubel J; Strasser S; Stuart KA; Dore G; Thompson A; Pianko S; Bollipo S; Mitchell JL; Fragomeli V; Jones T; Chivers S; Gow P; Iser D; Levy M; Tse E; Gazzola A; Cheng W; Nazareth S; Galhenage S; Wade A; Weltman M; Wigg A; MacQuillan G; Sasadeusz J; George J; Zekry A; Roberts SK, 2017, 'Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir ± ribavirin for hepatitis C genotype 1 – final results of the REV1TAL study', Antiviral Therapy, vol. 22, pp. 699 - 710, http://dx.doi.org/10.3851/IMP3168

Lee A; Rode A; Nicoll A; Zekry A; Lim L; Lim S; Angus P; Kronborg I; Arachchi N; McCaughan G; McLennan S; Shackel N, 2017, 'Soluble CD147 has an altered expression profile with liver disease progression and in different ethnicities', JOURNAL OF HEPATOLOGY, vol. 66, pp. S658 - S658, http://dx.doi.org/10.1016/S0168-8278(17)31783-X

Dowdell L; Zekry A, 2017, 'P13 Call: community assessment and liver liaison, a liver clinic provided to homeless men in their community', Journal of Virus Eradication, vol. 3, pp. 16 - 17, http://dx.doi.org/10.1016/s2055-6640(20)30754-8

Keoshkerian E; Hunter M; Cameron B; Nguyen N; Sugden P; Bull R; Zekry A; Maher L; Seddiki N; Zaunders J; Kelleher A; Lloyd AR; Dolan K; Haber P; Rawlinson W; Treloar C; Dore G; Luciani F, 2016, 'Hepatitis C-specific effector and regulatory CD4 T-cell responses are associated with the outcomes of primary infection', Journal of Viral Hepatitis, vol. 23, pp. 985 - 993, http://dx.doi.org/10.1111/jvh.12576

Chen FW; Zekry A, 2016, 'Elevated serum ferritin: Identifying iron overload', Medicine Today, vol. 7, pp. 51 - 52

Williams KH; Vieira De Ribeiro AJ; Prakoso E; Veillard AS; Shackel NA; Brooks B; Bu Y; Cavanagh E; Raleigh J; Mclennan SV; Mccaughan GW; Keane FM; Zekry A; Gorrell MD; Twigg SM, 2015, 'Circulating dipeptidyl peptidase-4 activity correlates with measures of hepatocyte apoptosis and fibrosis in non-alcoholic fatty liver disease in type 2 diabetes mellitus and obesity: A dual cohort cross-sectional study', Journal of Diabetes, vol. 7, pp. 809 - 819, http://dx.doi.org/10.1111/1753-0407.12237

Zeuzem S; Flisiak R; Vierling JM; Mazur W; Mazzella G; Thongsawat S; Abdurakhmanov D; Van Kinh N; Calistru P; Heo J; Stanciu C; Gould M; Makara M; Hsu S-J; Buggisch P; Samuel D; Mutimer D; Nault B; Merz M; Bao W; Griffel LH; Brass C; Naoumov NV, 2015, 'Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment-naive patients with chronic HCV genotype 1 infection (ESSENTIAL II)', ALIMENTARY PHARMACOLOGY & THERAPEUTICS, vol. 42, pp. 829 - 844, http://dx.doi.org/10.1111/apt.13342

Zhu AX; Park JO; Ryoo B-Y; Yen C-J; Poon R; Pastorelli D; Blanc J-F; Chung HC; Baron AD; Pfiffer TEF; Okusaka T; Kubackova K; Trojan J; Sastre J; Chau I; Chang S-C; Abada PB; Yang L; Schwartz JD; Kudo M, 2015, 'Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial', LANCET ONCOLOGY, vol. 16, pp. 859 - 870, http://dx.doi.org/10.1016/S1470-2045(15)00050-9

Williams KH; Viera de Ribeiro AJ; Prakoso E; Veillard AS; Shackel NA; Bu Y; Brooks B; Cavanagh E; Raleigh J; McLennan SV; McCaughan GW; Bachovchin WW; Keane FM; Zekry A; Twigg SM; Gorrell MD, 2015, 'Lower serum fibroblast activation protein shows promise in the exclusion of clinically significant liver fibrosis due to non-alcoholic fatty liver disease in diabetes and obesity', Diabetes Research and Clinical Practice, vol. 108, pp. 466 - 472, http://dx.doi.org/10.1016/j.diabres.2015.02.024

Sievert W, 2015, 'HCV-infected patients need access now to new direct-acting antiviral agents to avert liver-related deaths', MEDICAL JOURNAL OF AUSTRALIA, vol. 202, pp. VI - VI, http://dx.doi.org/10.5694/mja15.00165

Muir AJ; Arora S; Everson G; Flisiak R; George J; Ghalib R; Gordon SC; Gray T; Greenbloom S; Hassanein T; Hillson J; Horga MA; Jacobson IM; Jeffers L; Kowdley KV; Lawitz E; Lueth S; Rodriguez-Torres M; Rustgi V; Shemanski L; Shiffman ML; Srinivasan S; Vargas HE; Vierling JM; Xu D; Lopez-Talavera JC; Zeuzem S, 2014, 'A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection', Journal of Hepatology, vol. 61, pp. 1238 - 1246, http://dx.doi.org/10.1016/j.jhep.2014.07.022

Raghuraman S; Lloyd AR; Zekry A, 2014, 'Obese visceral adipose tissue exhibits altered T cell trafficking patterns and confers a unique phenotype to tissue-resident T cells', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol. 29, pp. 23 - 23, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343863000048&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bruggmann P; Berg T; Øvrehus ALH; Moreno C; Brandão Mello CE; Roudot-Thoraval F; Marinho RT; Sherman M; Ryder SD; Sperl J; Akarca U; Balık I; Bihl F; Bilodeau M; Blasco AJ; Buti M; Calinas F; Calleja JL; Cheinquer H; Christensen PB; Clausen M; Coelho HSM; Cornberg M; Cramp ME; Dore GJ; Doss W; Duberg AS; El-Sayed MH; Ergör G; Esmat G; Estes C; Falconer K; Félix J; Ferraz MLG; Ferreira PR; Frankova S; García-Samaniego J; Gerstoft J; Giria JA; Gonçales FL; Gower E; Gschwantler M; Guimarães Pessôa M; Hézode C; Hofer H; Husa P; Idilman R; Kåberg M; Kaita KDE; Kautz A; Kaymakoglu S; Krajden M; Krarup H; Laleman W; Lavanchy D; Lázaro P; Marotta P; Mauss S; Mendes Correa MC; Müllhaupt B; Myers RP; Negro F; Nemecek V; Örmeci N; Parkes J; Peltekian KM; Ramji A; Razavi H; Reis N; Roberts SK; Rosenberg WM; Sarmento-Castro R; Sarrazin C; Semela D; Shiha GE; Sievert W; Stärkel P; Stauber RE; Thompson AJ; Urbanek P; van Thiel I; Van Vlierberghe H; Vandijck D; Vogel W; Waked I; Wedemeyer H; Weis N; Wiegand J; Yosry A; Zekry A; Van Damme P; Aleman S; Hindman SJ, 2014, 'Historical epidemiology of hepatitis C virus (HCV) in selected countries', Journal of viral hepatitis, vol. 21, pp. 5 - 33, http://dx.doi.org/10.1111/jvh.12247

Wedemeyer H; Duberg AS; Buti M; Rosenberg WM; Frankova S; Esmat G; Örmeci N; Van Vlierberghe H; Gschwantler M; Akarca U; Aleman S; Balık I; Berg T; Bihl F; Bilodeau M; Blasco AJ; Brandão Mello CE; Bruggmann P; Calinas F; Calleja JL; Cheinquer H; Christensen PB; Clausen M; Coelho HSM; Cornberg M; Cramp ME; Dore GJ; Doss W; El-Sayed MH; Ergör G; Estes C; Falconer K; Félix J; Ferraz MLG; Ferreira PR; García-Samaniego J; Gerstoft J; Giria JA; Gonçales FL; Guimarães Pessôa M; Hézode C; Hindman SJ; Hofer H; Husa P; Idilman R; Kåberg M; Kaita KDE; Kautz A; Kaymakoglu S; Krajden M; Krarup H; Laleman W; Lavanchy D; Lázaro P; Marinho RT; Marotta P; Mauss S; Mendes Correa MC; Moreno C; Müllhaupt B; Myers RP; Nemecek V; Øvrehus ALH; Parkes J; Peltekian KM; Ramji A; Razavi H; Reis N; Roberts SK; Roudot-Thoraval F; Ryder SD; Sarmento-Castro R; Sarrazin C; Semela D; Sherman M; Shiha GE; Sperl J; Stärkel P; Stauber RE; Thompson AJ; Urbanek P; Van Damme P; van Thiel I; Vandijck D; Vogel W; Waked I; Weis N; Wiegand J; Yosry A; Zekry A; Negro F; Sievert W; Gower E, 2014, 'Strategies to manage hepatitis C virus (HCV) disease burden', Journal of viral hepatitis, vol. 21, pp. 60 - 89, http://dx.doi.org/10.1111/jvh.12249

Razavi H; Waked I; Sarrazin C; Myers RP; Idilman R; Calinas F; Vogel W; Mendes Correa MC; Hézode C; Lázaro P; Akarca U; Aleman S; Balık I; Berg T; Bihl F; Bilodeau M; Blasco AJ; Brandão Mello CE; Bruggmann P; Buti M; Calleja JL; Cheinquer H; Christensen PB; Clausen M; Coelho HSM; Cramp ME; Dore GJ; Doss W; Duberg AS; El-Sayed MH; Ergör G; Esmat G; Falconer K; Félix J; Ferraz MLG; Ferreira PR; Frankova S; García-Samaniego J; Gerstoft J; Giria JA; Gonçales FL; Gower E; Gschwantler M; Guimarães Pessôa M; Hindman SJ; Hofer H; Husa P; Kåberg M; Kaita KDE; Kautz A; Kaymakoglu S; Krajden M; Krarup H; Laleman W; Lavanchy D; Marinho RT; Marotta P; Mauss S; Moreno C; Murphy K; Negro F; Nemecek V; Örmeci N; Øvrehus ALH; Parkes J; Pasini K; Peltekian KM; Ramji A; Reis N; Roberts SK; Rosenberg WM; Roudot-Thoraval F; Ryder SD; Sarmento-Castro R; Semela D; Sherman M; Shiha GE; Sievert W; Sperl J; Stärkel P; Stauber RE; Thompson AJ; Urbanek P; Van Damme P; van Thiel I; Van Vlierberghe H; Vandijck D; Wedemeyer H; Weis N; Wiegand J; Yosry A; Zekry A; Cornberg M; Müllhaupt B; Estes C, 2014, 'The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm', Journal of viral hepatitis, vol. 21, pp. 34 - 59, http://dx.doi.org/10.1111/jvh.12248

Martinez D; Palmer C; Simar D; Cameron B; Nguyen N; Aggarwal V; Lloyd A; Zekry A, 2014, 'Characterization of the cytokine milieu associated with the upregulation of IL-6 and suppressor of cytokine 3 in chronic hepatitis C treatment non-responders', Liver International, vol. 35, pp. 463 - 472, http://dx.doi.org/10.1111/liv.12473

Roberts SK; Mitchell J; Leung R; Booth D; Bollipo S; Ostapowicz G; Sloss A; Mccaughan GW; Dore GJ; Thompson A; Crawford DH; Sievert W; Weltman M; Cheng W; George J; Angus P; Chu G; Cornwall M; Douglas M; Hallinan R; Haque M; Hawkin G; Jackson H; Johnson R; Kronborg I; Lee A; Leggett B; Mire ML; Levy M; Lubel J; MacQuillan G; Masson J; McDonald J; McGarity B; Mollison L; Nicoll A; Ombiga J; Riordan S; Roberts S; Strasser S; Thompson A; Watson J; Wenman J; Wigg A; Zekry A, 2014, 'Distribution of interferon lambda-3 gene polymorphisms in Australian patients with previously untreated genotype 1 chronic hepatitis C: Analysis from the PREDICT and CHARIOT studies', Journal of Gastroenterology and Hepatology (Australia), vol. 29, pp. 179 - 184, http://dx.doi.org/10.1111/jgh.12424

Sievert W; Razavi H; Estes C; Thompson AJ; Zekry A; Roberts SK; Dore GJ, 2014, 'Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C-related liver disease and costs in Australia', Journal of Gastroenterology and Hepatology (Australia), vol. 29, pp. 1 - 9, http://dx.doi.org/10.1111/jgh.12677

Nguyen N; de Esch C; Cameron B; Kumar RK; Zekry A; Lloyd AR, 2014, 'Positioning of leukocyte subsets in the portal and lobular compartments of hepatitis C virus-infected liver correlates with local chemokine expression', Journal of Gastroenterology and Hepatology (Australia), vol. 29, pp. 860 - 869, http://dx.doi.org/10.1111/jgh.12462

Back to profile page